These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22247456)

  • 41. Evaluation of CFH Y402H polymorphism and CFHR3/CFHR1 deletion in age-related macular degeneration patients from Brazil.
    Dezidério Sacconi DP; Cabral de Vasconcellos JP; Endo Hirata F; MacCord Medina F; Rim PH; Barbosa de Melo M
    Ophthalmic Genet; 2016 Dec; 37(4):459-461. PubMed ID: 26942649
    [No Abstract]   [Full Text] [Related]  

  • 42. Noncoding variant in the complement factor H gene and risk of exudative age-related macular degeneration in a Chinese population.
    Cui L; Zhou H; Yu J; Sun E; Zhang Y; Jia W; Jiao Y; Snellingen T; Liu X; Lim A; Wang N; Liu N
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1116-20. PubMed ID: 19850835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration.
    Deangelis MM; Ji F; Adams S; Morrison MA; Harring AJ; Sweeney MO; Capone A; Miller JW; Dryja TP; Ott J; Kim IK
    Ophthalmology; 2008 Jul; 115(7):1209-1215.e7. PubMed ID: 18164066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration.
    Wegscheider BJ; Weger M; Renner W; Steinbrugger I; März W; Mossböck G; Temmel W; El-Shabrawi Y; Schmut O; Jahrbacher R; Haas A
    Ophthalmology; 2007 Apr; 114(4):738-42. PubMed ID: 17398321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of c3 gene polymorphisms with neovascular age-related macular degeneration in a chinese population.
    Pei XT; Li XX; Bao YZ; Yu WZ; Yan Z; Qi HJ; Qian T; Xiao HX
    Curr Eye Res; 2009 Aug; 34(8):615-22. PubMed ID: 19899988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of complement factor H Y402H, LOC387715, HTRA1 polymorphisms and ApoE alleles with susceptibility to age-related macular degeneration in Hungarian patients.
    Losonczy G; Fekete Á; Vokó Z; Takács L; Káldi I; Ajzner É; Kasza M; Vajas A; Berta A; Balogh I
    Acta Ophthalmol; 2011 May; 89(3):255-62. PubMed ID: 19845562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels.
    Ristau T; Paun C; Ersoy L; Hahn M; Lechanteur Y; Hoyng C; de Jong EK; Daha MR; Kirchhof B; den Hollander AI; Fauser S
    PLoS One; 2014; 9(3):e93459. PubMed ID: 24675670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of the HTRA1 -625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population.
    Weger M; Renner W; Steinbrugger I; Köfer K; Wedrich A; Groselj-Strele A; El-Shabrawi Y; Schmut O; Haas A
    Mol Vis; 2007 Jul; 13():1274-9. PubMed ID: 17679948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic association study of age-related macular degeneration in the Spanish population.
    Brión M; Sanchez-Salorio M; Cortón M; de la Fuente M; Pazos B; Othman M; Swaroop A; Abecasis G; Sobrino B; Carracedo A;
    Acta Ophthalmol; 2011 Feb; 89(1):e12-22. PubMed ID: 21106043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complement factor H polymorphism in age-related macular degeneration.
    Klein RJ; Zeiss C; Chew EY; Tsai JY; Sackler RS; Haynes C; Henning AK; SanGiovanni JP; Mane SM; Mayne ST; Bracken MB; Ferris FL; Ott J; Barnstable C; Hoh J
    Science; 2005 Apr; 308(5720):385-9. PubMed ID: 15761122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of complement factor B rs4151667 (L9H) polymorphisms and its interactional role with CFH Y402H and C3 rs2230199 (R102G) risk variants in age-related macular degeneration: a case control study.
    Roshanipour N; Laleh MG; Bonyadi M; Bonyadi MHJ; Soheilian M; Javadzadeh A; Yaseri M
    BMC Ophthalmol; 2020 Aug; 20(1):323. PubMed ID: 32762675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
    Abedi F; Wickremasinghe S; Richardson AJ; Islam AF; Guymer RH; Baird PN
    Ophthalmology; 2013 Aug; 120(8):1641-8. PubMed ID: 23582991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CFH (rs1410996), HTRA1 (rs112000638) and ARMS2 (rs10490923) gene polymorphisms are associated with AMD risk in Spanish patients.
    Cruz-González F; Cieza-Borrella C; López Valverde G; Lorenzo-Pérez R; Hernández-Galilea E; González-Sarmiento R
    Ophthalmic Genet; 2014 Jun; 35(2):68-73. PubMed ID: 23534868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Functional Effect of Rare Variants in Complement Genes on C3b Degradation in Patients With Age-Related Macular Degeneration.
    Geerlings MJ; Kremlitzka M; Bakker B; Nilsson SC; Saksens NT; Lechanteur YT; Pauper M; Corominas J; Fauser S; Hoyng CB; Blom AM; de Jong EK; den Hollander AI
    JAMA Ophthalmol; 2017 Jan; 135(1):39-46. PubMed ID: 27918759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implications.
    Hageman GS; Hancox LS; Taiber AJ; Gehrs KM; Anderson DH; Johnson LV; Radeke MJ; Kavanagh D; Richards A; Atkinson J; Meri S; Bergeron J; Zernant J; Merriam J; Gold B; Allikmets R; Dean M
    Ann Med; 2006; 38(8):592-604. PubMed ID: 28950782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.
    Hageman GS; Anderson DH; Johnson LV; Hancox LS; Taiber AJ; Hardisty LI; Hageman JL; Stockman HA; Borchardt JD; Gehrs KM; Smith RJ; Silvestri G; Russell SR; Klaver CC; Barbazetto I; Chang S; Yannuzzi LA; Barile GR; Merriam JC; Smith RT; Olsh AK; Bergeron J; Zernant J; Merriam JE; Gold B; Dean M; Allikmets R
    Proc Natl Acad Sci U S A; 2005 May; 102(20):7227-32. PubMed ID: 15870199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration.
    Lorés-Motta L; Paun CC; Corominas J; Pauper M; Geerlings MJ; Altay L; Schick T; Daha MR; Fauser S; Hoyng CB; den Hollander AI; de Jong EK
    Ophthalmology; 2018 Jul; 125(7):1064-1074. PubMed ID: 29398083
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration.
    Seitsonen SP; Onkamo P; Peng G; Xiong M; Tommila PV; Ranta PH; Holopainen JM; Moilanen JA; Palosaari T; Kaarniranta K; Meri S; Immonen IR; Järvelä IE
    PLoS One; 2008; 3(12):e3833. PubMed ID: 19048105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.
    Rivera A; Fisher SA; Fritsche LG; Keilhauer CN; Lichtner P; Meitinger T; Weber BH
    Hum Mol Genet; 2005 Nov; 14(21):3227-36. PubMed ID: 16174643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective study of common variants in CX3CR1 and risk of macular degeneration: pooled analysis from 5 long-term studies.
    Schaumberg DA; Rose L; DeAngelis MM; Semba RD; Hageman GS; Chasman DI
    JAMA Ophthalmol; 2014 Jan; 132(1):84-95. PubMed ID: 24287500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.